David A. Socks, Director at Phathom Pharmaceuticals, Inc. (PHAT), sold 36,000 shares at $31.49 ($1.1M) on 2021-08-16, disclosed to the SEC on 2021-08-18.
Open-market sale of $1.1M PHAT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.47 | 4,209 | $128K | 11.4% |
| 2 | $30.47 | 4,209 | $128K | 11.4% |
| 3 | $31.49 | 13,791 | $434K | 38.6% |
| 4 | $31.49 | 13,791 | $434K | 38.6% |
| Total | $31.25 avg | 36,000 | $1.1M | 100% |
| Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |
| PHAT | SELL | 2021-04-07 | $2.9M | — | Filing → |